Innate Pharma Reports First Quarter 2026 Business Update and Financial Results
· for additional information, please contact:
AI Briefing
- Innate Pharma reports solid progress on clinical assets, nearing completion of Phase 1 enrollment in IPH4502.
- Company advances negotiations with partners and prepares for upcoming milestones.
- Financial results to be released on May 11, 2026.
Advertisement